{
    "startDate": "2020-01-01",
    "endDate": "2020-12-31",
    "year": "2020",
    "quarter": "FY",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 1331200000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1278900000.0
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1913800000.0
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DueFromUnconsolidatedJointBusiness",
                "unit": "usd",
                "value": 413500000.0
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 1068599999.9999999
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 881100000.0
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 6887100000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
                "unit": "usd",
                "value": 772100000.0
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3411500000.0
            },
            {
                "label": "Operating lease assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 433300000.0
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3084300000.0
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5762100000.0
            },
            {
                "label": "Deferred tax asset",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 1369500000.0
            },
            {
                "label": "Investments and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 2899000000.0
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 24618900000.0
            },
            {
                "label": "Current portion of notes payable",
                "concept": "DebtCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 142000000.0
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 454900000.0
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 3145300000.0
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3742200000.0
            },
            {
                "label": "2023",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 7426200000.0
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 1032800000.0
            },
            {
                "label": "Long-term operating lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 402000000.0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1329600000.0
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 13932800000.0
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000.0
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -299000000.0
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 13976300000.0
            },
            {
                "label": "Repurchase of common stock pursuant to the share repurchase program, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000.0
            },
            {
                "label": "Total Biogen Inc. shareholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 10700300000.0
            },
            {
                "label": "Distribution to noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -14200000.0
            },
            {
                "label": "Total equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 10686100000.0
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 24618900000.0
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 4060500000.0
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 457200000.0
            },
            {
                "label": "Impairment of intangible assets",
                "concept": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
                "unit": "usd",
                "value": 209700000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Granted (in shares)",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 198300000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 86300000.0
            },
            {
                "label": "(Gain)/loss on divestiture of Hillerod, Denmark manufactuing operations",
                "concept": "IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToParentBeforeIncomeTax",
                "unit": "usd",
                "value": 92500000.0
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 149000000.0
            },
            {
                "label": "Unrealized (gain) loss on strategic investments",
                "concept": "IncreaseDecreaseInEquitySecuritiesFvNi",
                "unit": "usd",
                "value": 681800000.0
            },
            {
                "label": "Loss on equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 3300000.0
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -131199999.99999999
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -2800000.0
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": -176700000.0
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 316300000.0
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 154200000.0
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": -67500000.0
            },
            {
                "label": "Other changes in operating assets and liabilities, net",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": -137100000.0
            },
            {
                "label": "Net cash flows provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 4229800000.0
            },
            {
                "label": "Proceeds from sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 7299400000.0
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 6397700000.0
            },
            {
                "label": "Contingent consideration paid related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Acquisition of Nightstar Therapeutics plc, net of cash acquired",
                "concept": "PaymentsToAcquireBusinessTwoNetOfCashAcquired",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from divesiture of Hillerod, Denmark manufacturing operations",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 424800000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 52000000.0
            },
            {
                "label": "Investment in Samsung Bioepis",
                "concept": "PaymentsToAcquireEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from sales of strategic investments",
                "concept": "ProceedsFromSaleOfEquityMethodInvestments",
                "unit": "usd",
                "value": 74900000.0
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": 26900000.0
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -608600000.0
            },
            {
                "label": "Purchase of treasury stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 6679100000.0
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": 4600000.0
            },
            {
                "label": "Proceeds from borrowings",
                "concept": "ProceedsFromIssuanceOfLongTermDebt",
                "unit": "usd",
                "value": 2967400000.0
            },
            {
                "label": "Repayments of borrowings",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": 1500000000.0
            },
            {
                "label": "Net contribution (distribution) to noncontrolling interest",
                "concept": "PaymentsOfCapitalDistribution",
                "unit": "usd",
                "value": 71000000.0
            },
            {
                "label": "Contingent consideration payments",
                "concept": "PaymentForContingentConsiderationLiabilityFinancingActivities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 14600000.0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -5272700000.0
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": -1651500000.0
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 69000000.0
            }
        ],
        "ic": [
            {
                "label": "Total revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 13444600000.0
            },
            {
                "label": "Cost of sales, excluding amortization and impairment of acquired intangible assets",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1805200000.0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 3990900000.0
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2504500000.0
            },
            {
                "label": "Amortization and impairment of acquired intangible assets",
                "concept": "biib:AmortizationandImpairmentofAcquiredIntangibleAssets",
                "unit": "usd",
                "value": 464800000.0
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:CollaborationProfitSharing",
                "unit": "usd",
                "value": 232900000.0
            },
            {
                "label": "(Gain) loss on divestiture of Hiller\u00f8d, Denmark manufacturing operations",
                "concept": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
                "unit": "usd",
                "value": -92500000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 86300000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cost and expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 8894500000.0
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 4550100000.0
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 497400000.0
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5047500000.0
            },
            {
                "label": "Income tax expense (benefit)",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 992300000.0
            },
            {
                "label": "Equity in (income) loss of investee, net of tax",
                "concept": "biib:IncomeLossFromEquityMethodInvestmentsNetOfTax",
                "unit": "usd",
                "value": 5300000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 4060500000.0
            },
            {
                "label": "Net income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 59900000.0
            },
            {
                "label": "Net income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 4000600000.0
            },
            {
                "label": "Net income per share:",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 24.86
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc. (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 24.8
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc. (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 160900000.0
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc. (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 161300000.0
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -2800000.0
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
                "unit": "usd",
                "value": -186800000.0
            },
            {
                "label": "Gains (losses) on net investment hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
                "unit": "usd",
                "value": -33600000.0
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": 33500000.0
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 92900000.0
            },
            {
                "label": "Other comprehensive income:",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -163800000.0
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 3836800000.0
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 60900000.0
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 3897700000.0
            }
        ]
    }
}